Q3 2022 Holdings
Filed 2022-11-09 | 25 holdings | $50.3M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Cullinan Oncology Inc(CGEM) | COM | 230031106 | $41.6M | 3,243,185 | 82.7% |
| Compass Therapeutics Inc(CMPX) | COM | 20454B104 | $6.5M | 2,829,712 | 12.8% |
| Corvus Pharmaceuticals Inc(CRVS) | COM | 221015100 | $2.0M | 2,384,402 | 3.9% |
| Prometheus Biosciences Inc | COM | 74349U108 | $94.5K | 1,601,785 | 0.2% |
| Pliant Therapeutics Inc(PLRX) | COM | 729139105 | $71.2K | 3,409,758 | 0.1% |
| Repare Therapeutics Inc(RPTX) | COM | 760273102 | $37.2K | 3,069,847 | 0.1% |
| Vectivbio Hldg AG | ORD SHS | H9060V101 | $24.7K | 4,119,572 | 0.0% |
| Kezar Life Sciences Inc | COM | 49372L100 | $15.2K | 1,762,793 | 0.0% |
| Larimar Therapeutics Inc(LRMR) | COM | 517125100 | $10.9K | 3,415,148 | 0.0% |
| Akouos Inc | COM | 00973J101 | $8.7K | 1,288,358 | 0.0% |
| 2Seventy BIO Inc(TSVT*) | COMMON STOCK | 901384107 | $7.7K | 530,223 | 0.0% |
| Keros Therapeutics Inc(KROS) | COM | 492327101 | $7.5K | 200,229 | 0.0% |
| Omega Therapeutics Inc | COMMON STOCK | 68217N105 | $5.7K | 1,055,882 | 0.0% |
| Inozyme Pharma Inc | COM | 45790W108 | $5.4K | 1,996,277 | 0.0% |
| Precision Biosciences Inc | COM | 74019P108 | $4.8K | 3,674,820 | 0.0% |
| Ikena Oncology Inc | COM | 45175G108 | $4.3K | 1,214,304 | 0.0% |
| G1 Therapeutics Inc(GTHXEUR) | COM | 3621LQ109 | $4.0K | 323,945 | 0.0% |
| Orchard Therapeutics PLC | SPON ADS | 68570P101 | $4.0K | 7,987,396 | 0.0% |
| Eiger Biopharmaceuticals Inc(CLDNEUR) | COM | 28249U105 | $3.4K | 455,100 | 0.0% |
| Freeline Therapeutics Hldgs | SPONSORED ADS | 35655L107 | $3.4K | 4,814,419 | 0.0% |
| Rallybio Corp | COM | 75120L100 | $2.8K | 194,297 | 0.0% |
| Oncorus Inc | COM | 68236R103 | $2.0K | 2,367,436 | 0.0% |
| Ovid Therapeutics Inc(OVID) | COM | 690469101 | $1.6K | 864,822 | 0.0% |
| Nkarta Inc(NKTX) | COM | 65487U108 | $1.5K | 117,599 | 0.0% |
| Direxion SHS ETF TR(LABDUSD) | DAILY S&P BIOTEC | 25460G716 | $1.2K | 50,000 | 0.0% |